Get started
Author

Joaquin Rodriguez Galvan

Observed name: Joaquín J Rodriguez Galvan
Institution: New York University
ORCID: 0000-0001-5886-9567
Observed ORCID: 0000-0001-5886-9567
OpenAlex ID: A5079190865
Multivalent binding of the partially disordered SARS-CoV-2 nucleocapsid phosphoprotein dimer to RNA
2021 · Heather M. Forsythe, Joaquin Rodriguez Galvan, et al. · Biophysical Journal · 45
PDF
A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8
2023 · Bruno A. Rodriguez-Rodriguez, Grace O. Ciabattoni, et al. · Nature Communications · 12
PDF
Human Parainfluenza Virus 3 Phosphoprotein Is a Tetramer and Shares Structural and Interaction Features with Ebola Phosphoprotein VP35
2021 · Joaquin Rodriguez Galvan, Brianna Donner, et al. · Biomolecules · 8
PDF
Host cell and viral protease targets of human SERPINs identified by in silico docking
2025 · Joaquin Rodriguez Galvan, Maren de Vries, et al. · The EMBO Journal · 3
PDF
In-silico docking platform with serine protease inhibitor (SERPIN) structures identifies host cysteine protease targets with significance for SARS-CoV-2
2022 · Joaquín J Rodriguez Galvan, Maren de Vries, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Airway protease availability governs a reversible shift between syncytial and cell-free spread
2026 · Joaquin Rodriguez Galvan, Maren de Vries, et al. · Journal of Virology
Author Reply to Peer Reviews of In-silico docking with serine protease inhibitors (SERPINs) identifies alternate protease targets with significance for SARS-CoV-2
2024 · Joaquin Rodriguez Galvan, Maren de Vries, et al.
Works count: 7
Citation count: 69
H-index: 3
I10-index: 2
Year
Topic
Type